Featured News
EIN Presswire: CGT Global Receives Approval Aiding Scientists in Discovering Life-Saving Cures
CGT Global, a leading Contract Research Organization (CRO) & biotech manufacturer announced approval to provide disease state leukopaks to researchers worldwide FOLSOM, CALIFORNIA, UNITED STATES, June 11, 2024 /EINPresswire.com/ — CGT Global, a leading international Contract Research Organization (CRO) and biotech manufacturer, announced today it has received approval from Western Copernus Group (WCG) to provide disease…
For More InformationEIN Presswire: CGT Global and Austin Financial Partner to Drive Momentum for Cutting-Edge Cell Therapy Treatments and Cures
CGT Global, leader in human cell collection, partners with Austin Financial Services to expedite cell & gene therapy research for life-threatening conditions. FOLSOM, CALIFORNIA, USA, March 20, 2024 /EINPresswire.com/ — A world leader in human cell collection and manufacturing, CGT Global announced today it is partnering with Austin Financial Services, Inc., a leading national middle…
For More InformationEIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States
FOLSOM, CA, UNITED STATES, December 6, 2023 /EINPresswire.com/ — CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has 60 cell and gene therapy mobile laboratories currently deployed in Europe and Asia. CGT Global…
For More InformationCGT Global introduces Clinical Commercial Solutions Guide including Clinical Donor Screening
StemExpress introduces Clinical Commercial Solutions Guide including Clinical Donor Screening By StemExpress January 16, 2023 StemExpress has published its full Clinical Commercial Solutions Guide and launched their new Clinical Donor Screening services. Now, researchers and therapeutic developers can discover how StemExpress is utilizing a nationwide & coast-to-coast footprint of privately owned and operated collection facilities to support the…
For More InformationCGT Global Launches CellsExpress Bulk Cell Isolation
StemExpress Launches CellsExpress Bulk Cell Isolation Researchers can maximize their isolated cell output, saving valuable time and budget better spent on their research. FOLSOM, Calif. , /PRNewswire/ — As a trusted provider of high-quality isolated human stem and immune cells for over a decade, StemExpress is now proud to offer select isolated products in bulk…
For More InformationCEO & Founder Cate Dyer Discusses Cell & Gene Therapies with the Video Journal of Regenerative Medicine
Cate’s discussion focused on the importance of creating a closed-loop system for cell and gene clinical therapies by leveraging existing partnerships with hospital systems and the 8 U.S.-based StemExpress clinical collection centers within nearby proximity to industry-leading hospital systems.
For More Information2022 Advanced Therapies Week Audiogram
Live from Phacilitate’s 2022 Advanced Therapies Week in Miami, Florida Take a moment to watch the audiogram of Cate Dyer, CEO & Founder of StemExpress, speak on the importance of partnerships in cell therapy at Phacilitate’s 2022 Advanced Therapies Week. Picking the Right Partner from Product and Process Development Through Commercialization Qualifying how…
For More InformationBiocom California Member Spotlight
Biocom California recently sat down with Cate Dyer, CEO & Founder of StemExpress to hear what it took to bring her vision to life and how the company built an end-to-end COVID-19 testing solution in a matter of weeks from the very beginning of the pandemic. The article discusses (1) the roots of StemExpress, (2)…
For More Information